A Pilotstudy Investigating Feasability, Acceptability and Preliminary Effects of ISTDP (Intensive Short Term Dynamic Psychotherapy) for Patients with Personality Disorder in a Psychiatric Clinic Specialized on Depression, Anxiety and PTSD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Personality Disorder
- Sponsor
- Karolinska Institutet
- Enrollment
- 34
- Locations
- 1
- Primary Endpoint
- Patients experience of, and satisfaction with, the treatment assessed through qualitative interviews
- Status
- Enrolling By Invitation
- Last Updated
- last year
Overview
Brief Summary
The primary objective of this study is to evaluate the feasibility and acceptability of a 25-week combined group and individual therapy program using Intensive Short-Term Dynamic Psychotherapy (ISTDP) for patients diagnosed with personality disorders. The secondary objective is to investigate preliminary effects of the treatment in terms of reducing symtoms of depression, anxiety and emotion regulation difficulties.
Detailed Description
The investigators vill investigate a 25-week treatment with ISTDP that consists of both weekly group- and individual therapy for patients diagnosed with personality disorder in a psychiatric clinic specialized on depression, anxiety and PTSD. The feasibility and acceptability and preliminary effects will be evaluated using a within-group design with repeated measures and qualitative interviews. Patients will be recruited from the clinic and the main inclusion criteria is that the patient have a personality disorder diagnosis.
Investigators
Maria Bragesjo
PhD and licensed psychologist
Karolinska Institutet
Eligibility Criteria
Inclusion Criteria
- •Personality disorder diagnosis (Clinical assessment using STIP-5) Speaks Swedish fluently
Exclusion Criteria
- •Autism or intellectual disability Borderline, antisocial or narcissistic personality disorder diagnosis Need for interpreter Urgent social misery Psychotic disorder High suicidality
Outcomes
Primary Outcomes
Patients experience of, and satisfaction with, the treatment assessed through qualitative interviews
Time Frame: Immediately after treatment completion
Patients experience of, and satisfaction with, the treatment assessed through qualitative interviews
Depression symtoms
Time Frame: Baseline, weekly throughout treatment, immediately after treatment completion and 6-month follow-up
Depression symtoms will be measured with Patient Health Questionnaire (PHQ-9; (Kroenke et al., 2001)
Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Immediately after treatment completion (25 weeks)
Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8)
Adverse events related to the treatment
Time Frame: From start of treatment up to. 6 month follow up.
Adverse events related to the treatment
Number of individual sessions attended during the treatment
Time Frame: Throughout the treatment period, up to 25 weeks
Number of individual sessions attended during the treatment
Number of group sessions attended during the treatment
Time Frame: Throughout the treatment period, up to 25 weeks
Number of group sessions attended during the treatment
Number of dropouts
Time Frame: Throughout the treatment period, up to 25 weeks
Number of dropouts
Total number of sessions attended during the treatment
Time Frame: Throughout the treatment period, up to 25 weeks
Total number of sessions attended during the treatment
Secondary Outcomes
- Fear of negative emotions(Change from baseline to post-treatment (25 weeks) and follow up 6 months after treatment.)
- Anxiety symtoms(Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.)
- Symtoms of Borderline Personality disorder(Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.)
- Emotions regulation difficulties(Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.)
- Severity of personality disorder(Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.)
- Quality of life(Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.)
- Working alliance(Weekly throughout treatment , up to 25 weeks)
- Emotional activation during therapy(Weekly throughout treatment, up to 25 weeks)